Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - mitozantrone hydrochloride, quantity: 2.328 mg/ml (equivalent: mitozantrone, qty 2 mg/ml) - injection, concentrated - excipient ingredients: sodium chloride; glacial acetic acid; sodium acetate; water for injections - for the treatment of *locally advanced or metastatic carcinoma of the breast *non-hodgkin's lymphoma *adult acute non-lymphocytic leukaemia (anll) *chronic myelogenous leukaemia in blast crisis.

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - mitoxantrone - concentrate for solution for infusion - mitoxantrone 2 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - mitoxantrone - concentrate for solution for infusion - mitoxantrone 2 mg/ml - antineoplastic agents

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - mitoxantrone - concentrate for solution for infusion - mitoxantrone 2 mg/ml - antineoplastic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - ondansetron hydrochloride dihydrate - solution for injection/infusion in pre-filled syringe - 2 milligram(s)/millilitre - ondansetron

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

accord healthcare polska sp. z o.o. - ondansetron (ondansetron hydrochloride dihydrate) - solution for injection/infusion - 8mg/4ml

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

hisun pharmaceuticals usa, inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride injection is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

hisun pharmaceuticals usa, inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride injection is contraindicated in patients who have shown a hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

hisun pharmaceuticals usa, inc. - daunorubicin hydrochloride (unii: ud984i04lz) (daunorubicin - unii:zs7284e0zp) - daunorubicin hydrochloride injection in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults. daunorubicin hydrochloride injection is contraindicated in patients who have shown a hypersensitivity to it.